<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Earlier work demonstrated that the transcription factor C/EBPα can convert immature and mature murine B lineage cells into functional macrophages </plain></SENT>
<SENT sid="1" pm="."><plain>Testing &gt;20 human <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> B cell lines, we found that most can be transdifferentiated at least partially into macrophage-like cells, provided that C/EBPα is expressed at sufficiently high levels </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>-inducible subclone of the Seraphina Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line, expressing C/EBPαER, could be efficiently converted into phagocytic and quiescent cells with a transcriptome resembling <z:mpath ids='MPATH_458'>normal</z:mpath> macrophages </plain></SENT>
<SENT sid="3" pm="."><plain>The converted cells retained their phenotype even when C/EBPα was inactivated, a hallmark of cell reprogramming </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, C/EBPα induction also impaired the cells' tumorigenicity </plain></SENT>
<SENT sid="5" pm="."><plain>Likewise, C/EBPα efficiently converted a lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> B cell line into macrophage-like cells, again dramatically impairing their tumorigenicity </plain></SENT>
<SENT sid="6" pm="."><plain>Our experiments show that human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells can be induced by C/EBPα to transdifferentiate into seemingly <z:mpath ids='MPATH_458'>normal</z:mpath> cells at high frequencies and provide a proof of principle for a potential new therapeutic strategy for treating B cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>